Business Context and Reporting Period
This Form 6-K filing by Haoxi Health Technology Ltd, a foreign private issuer, covers the month of November 2025. The report, dated November 12, 2025, discloses "Other Events" specifically regarding the convening of an Extraordinary General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a procedural notice for a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The primary event is the solicitation of proxies for the Extraordinary General Meeting.
Guidance, Outlook, and Risks
Management commentary is limited to the procedural details of the shareholder meeting. The filing notes that the Notice of the Extraordinary General Meeting and Proxy Card are attached as Exhibits 99.1 and 99.2. It explicitly states that the Notice is not subject to review by the SEC. Shareholders are urged to read the Notice for important information regarding the Company and the meeting. No specific risks, contingencies, or unusual items are detailed in the main body of this report.
Key Facts for Investor Verification
- Verify the specific agenda items and proposals contained in the attached Notice of Extraordinary General Meeting (Exhibit 99.1).
- Confirm the record date and voting procedures outlined in the Proxy Card (Exhibit 99.2).
- Review the Company's website (http://www.haoximedia.com/) for the full text of the Notice and other filings.
- Note that the filing is signed by Zhen Fan, Chief Executive Officer, on November 12, 2025.